Director/PDMR Shareholding

RNS Number : 0595S

GlaxoSmithKline PLC

11 May 2009

 



 Notification of Transactions of Directors, Persons Discharging 

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 11 May 2009 of an increase in their notional interests in Ordinary shares at a price of £10.39 per share and Ordinary Share ADRs at a price of $30.85 per ADR following the notional re-investment of the dividend to be paid to shareholders on 9 July 2009.

	Ordinary shares	ADRs
Mr A P Witty	5,302.48
Mr J S Heslop	3,034.13
Dr M M Slaoui		1,965.07
Mrs C E Bruck Slaoui		79.47
Mr S M Bicknell	256.60
Mr J M Clarke	2,225.03
Mr M Dunoyer	838.00
Mr E J Gray	881.14
Mr S A Hussain	627.86
Mr D Learmouth	614.05
Mr W C Louv		711.98
Mr D J Phelan		1,096.45
Dr D Pulman		711.98
Mr D S Redfern	340.98
Mr J R Stéphenne	768.65
Ms C Thomas	256.60
Mr D E Troy		776.88

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a). 

V A Whyte

Deputy Company Secretary

11 May 2009

 

END

 

 

RDSEFLFFKEBEBBB